William Patrick Burke is CHRO at NovoCure Ltd (NVCR). They have made 7 open-market trades across 1 company since 2022, most recently 2023-06-30.
CIK 0001880493
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NVCR | 66,447 | $970K |
Shares reported on the most recent Form 4, priced at the 2023-07-06 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NVCR | SELL | 2023-03-03 | 2023-03-07 | $76.16 | $45K | -23.5% | -15.5% | +10.6% |
| NVCR | SELL | 2023-03-02 | 2023-03-06 | $75.28 | $21K | -14.8% | -17.9% | +9.1% |
| NVCR | SELL | 2023-03-01 | 2023-03-02 | $76.36 | $115K | -11.2% | -20.6% | -5.2% |
| NVCR | SELL | 2022-09-02 | 2022-09-06 | $79.04 | $114K | +10.6% | +8.5% | -0.8% |
| NVCR | SELL | 2022-03-08 | 2022-03-09 | $70.10 | $145K | +8.0% | +18.3% | +7.9% |
| NVCR | SELL | 2022-03-03 | 2022-03-07 | $70.99 | $170K | +12.5% | +25.0% | +15.6% |
| NVCR | SELL | 2022-01-03 | 2022-01-05 | $76.00 | $570K | -9.3% | +0.3% | +22.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.